文献速递免疫规划

母体抗体对泰国婴儿接种麻腮风疫苗反应影响的评估

Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants.
PubMed 文献 · Vaccine · 2022-02-05

研究采用假型病毒中和试验检测泰国婴儿在两剂麻腮风疫苗接种前后六个时间点的中和抗体滴度。母体免疫水平高的婴儿在首剂接种时未有效产生保护性滴度,但第二剂后反应显著更高(P=0.0171)。抗麻疹IgG水平与中和抗体滴度相关,提示可用快速IgG检测作为替代指标。

要点

  • 母体免疫水平高的婴儿首剂麻腮风疫苗后未有效产生保护性抗体滴度。
  • 母体免疫水平低的婴儿接种后产生了保护性抗体滴度。
  • 高母体免疫组第二剂麻腮风疫苗后抗体反应显著更高(P=0.0171)。

核心结论

  • 根据获得性母体免疫水平调整首剂麻腮风疫苗接种时机可提高免疫原性,从而加速麻疹消除。

研究设计与样本

  • 采用假型病毒中和试验检测泰国婴儿在两剂麻腮风疫苗接种前后六个时间点采集的血清样本中的中和抗体滴度(ClinicalTrials.gov编号NCT02408926)。

主要发现

  • 母体免疫水平高的婴儿在首剂麻腮风疫苗接种时中和抗体滴度持续存在,但未能有效产生保护性滴度。
  • 母体免疫水平低的婴儿接种后产生了保护性抗体滴度。
  • 高母体免疫组第二剂麻腮风疫苗接种后的抗体反应显著更高(P=0.0171,Wilcoxon符号秩检验)。
  • 泰国婴儿抗麻疹IgG水平与中和抗体滴度之间存在相关性,提示可用快速IgG检测作为替代指标来定义人群中的临床保护水平。

关键数值与推荐

  • 中和抗体滴度定义为使荧光素酶活性降低90%的血清稀释度。

临床怎么用

  • 作者认为,根据获得性母体免疫水平调整首剂麻腮风疫苗接种时机可提高疫苗接种的免疫原性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although the number of measles cases declined globally in response to anti-measles immunisation campaigns, measles has re-emerged. A review of current vaccination policies is required to improve measles elimination strategies. METHODS: A pseudotype-based virus neutralisation assay (PVNA) was used to measure neutralising antibody titres in serum samples collected from Thai infants at six timepoints before and after two-doses of MMR (1&2) vaccination (ClinicalTrials.gov no. NCT02408926). Vesicular stomatitis virus (VSV) luciferase pseudotypes bearing the haemaglutinin (H) and fusion (F) glycoproteins of measles virus (MeV) were prepared. Serial dilutions of serum samples were incubated with VSV (MeV) pseudotypes and plated onto HEK293-human SLAM1 cells; the neutralising antibody titre was defined as the dilution resulting in 90% reduction in luciferase activity. RESULTS: Neutralising antibody titres in infants born with high levels of maternal immunity (H group) persisted at the time of the first MMR vaccination, and those infants did not respond effectively by developing protective titres. In contrast, infants with lower maternal immunity (L group) developed protective titres of antibody following vaccination. Responses to the second MMR vaccination were significantly higher (P = 0.0171, Wilcoxon signed-rank test) in the H group. The observed correlation between anti-MeV IgG level and neutralising antibody titre in Thai infants indicates the possibility of using rapid IgG testing as a surrogate measure for neutralising activity to define clinical protection levels within populations. CONCLUSION: These results demonstrate that varying the timing of the first MMR immunisation according to the level of acquired maternal immunity could increase vaccination immunogenicity and hence accelerate measles eradication.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hu S, Logan N, Puenpa J, et al. Evaluation of the effect of maternally derived antibody on response to MMR vaccine in Thai infants. Vaccine. 2022. PMID: 35135700. doi:10.1016/j.vaccine.2022.01.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。